Our sponsors

TERMIS-AP 2026 acknowledge and thank the sponsors listed below, without whom the conference would not be possible.

TERMIS BMEF Logo

Silver sponsor | Coffee cart

BMEF (BME Frontiers) is a Science Partner Journal distributed by the American Association for the Advancement of Science (AAAS) in collaboration with the Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences (SIBET CAS). The scope of BMEF includes the following topics: biomedical imaging, biomedical devices, biomaterials and nanomedicine, translational medicine, and AI for advanced biomedical applications. BMEF is indexed in CNKI, DOAJ, Inspec, PubMed Central, Scopus, ESCI, and Ei Compendex. In 2025, BMEF achieved a Journal Impact Factor (JIF) of 9.1 and a CiteScore of 12.4, ranking in the top quartile (Q1) of biomedical engineering journals. 

TERMIS Cellink Logo V2

Silver sponsor | Lanyard and name badge

As the leading 3D bioprinting company, CELLINK is committed to providing the most advanced 3D bioprinting products, services and technologies needed to understand and master biology. We develop technologies that democratize 3D bioprinting – providing the leading researchers in the world the tools they need to create the future of health. Whether it is developing and utilizing alternatives to animal models, accelerating drug discovery, rethinking regenerative medicine or developing tissue engineered organs to treat diseases previously considered untreatable.

TERMIS Aroa Biosurgery Logo V2

SYIS networking event sponsor

AROA Biosurgery is a soft-tissue regeneration company based in Auckland, New Zealand. Its proprietary AROA ECM™ technology is derived from ovine forestomach matrix, an extracellular matrix biomaterial that retains native tissue architecture and biological complexity to support vascularisation, cell recruitment and constructive tissue remodelling. AROA has translated this platform into products for chronic wound care, complex soft-tissue reconstruction and abdominal wall repair. These products have been used to treat more than seven million wounds worldwide and are supported by over 120 peer-reviewed publications spanning fundamental ECM biology, preclinical research and clinical outcomes. Through integrated research, product development and advanced manufacturing, AROA transforms a by-product of New Zealand’s pastoral industry into globally used regenerative technologies. AROA collaborates with clinicians, scientists and research institutions internationally to advance understanding of extracellular matrix biology and develop new approaches to tissue regeneration.

TERMIS ACS Publications logo V2

Award sponsor

ACS Publications supports researchers through journals, eBooks, scientific programs, and the news magazine Chemical & Engineering News. With a comprehensive portfolio of 90+ journals, including 22 open-access journals, ACS Publications has a home for every type of research. ACS Publications has a robust portfolio of Materials Science, Biological Chemistry, and Chemical Biology journals that publish research across all areas of tissue engineering and regenerative medicine. Some notable titles include "ACS Applied Materials & Interfaces, ACS Nano, ACS Biomaterials Science & Engineering, Nano Letters, ACS Applied Bio Materials, Bioconjugate Chemistry, and Biomacromolecules.

TERMIS Shibuya Logo

Student sponsor

Shibuya Corporation is leveraging the aseptic and automation technologies it has cultivated through the development of pharmaceutical manufacturing systems in order to develop automated cell manufacturing systems that support the industrialization of cell therapy.
Shibuya offers “Shibuya Cell Factory,” a comprehensive cell manufacturing platform, as a solution.

The “Cell Factory Solution” provided by Shibuya consists of the following products and technologies:

  • Hardware that enables the aseptic and automation of manufacturing processes
  • Software for planning cell production and managing quality and environmental data

Moving forward, Shibuya will continue to provide total solutions that support the commercialization of regenerative medicine and cell manufacturing.